What we're reading, June 7, 2016: opioid restrictions disproportionately affect older patients with chronic pain; Genentech and OSI Pharmaceuticals settle Tarceva lawsuit; and trouble raising Zika virus funds.
With a growing opioid epidemic, new restrictions are making it more difficult to obtain painkillers. Unfortunately, while abuse and misuse of opioids is higher among younger patients, restrictions are disproportionately affecting the elderly, who rely on opioids for chronic pain, reported The New York Times. Older patients are more likely to have painful musculoskeletal disorders, nerve damage, and surgery, and they need treatment to deal with the pain they feel. Unfortunately, this population is also more likely to suffer the ill effects of these drugs, so physicians are left pondering the trade-offs.
Genentech and OSI Pharmaceuticals are paying $67 million to settle a lawsuit over the drug Tarceva. According to the AP, the lawsuit involved allegations that the 2 companies misled physicians about the effectiveness of the lung cancer drug. Neither company is acknowledging wrongdoing.
Raising funds to fight the Zika virus outbreak has been difficult. While the world is alarmed by Zika, and the devastating birth defects it causes, Congress has not approved funding for the United States, the World Health Organization has received a small fraction of the money it requested, and the United Nations isn’t receiving much money either, reported STAT. The problem is that the majority of people affected by Zika show no or mild symptoms, and following the Ebola crisis, donors are fatigued.
Contributor: For Complex Cases, Continuity in Acute Care Is Necessary
April 23rd 2025For patients with complex needs and social challenges like unstable housing, the hospital has become their de facto medical home—yet each visit is a fragmented restart, without continuity, context, or a clear path forward.
Read More
Higher Weight-Adjusted Waist Index Tied to Greater Mortality Risk in Patients With Osteoarthritis
April 23rd 2025Researchers consider the weight-adjusted waist index a more precise predictor of mortality risk in patients with osteoarthritis than traditional obesity measures, like body mass index.
Read More